AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2024
Mar 22, 2024
33956_dirs_2024-03-21_2da1b210-07d6-473e-8f66-dac60aa04a78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2024-03-19
Reporting Person: SOSIN CLIFFORD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-19 | Common Stock | P | 350000 | $14.1601 | Acquired | 6373676 | Indirect |
Footnotes
F1: 4,292,156 of these shares are owned directly by Sosin Master, L.P. ("Sosin Master"). The Reporting Person, as the Managing Member of CAS Investment Partners, LLC ("CAS"), the investment manager to Sosin Master, may be deemed to beneficially own the securities directly owned by Sosin Master. The remaining 2,081,520 shares are owned directly by CSWR Partners, L.P. ("CSWR"). The Reporting Person, as the Managing Member of CAS, the investment manager to CSWR, may be deemed to beneficially own the securities directly owned by CSWR.
More from Cardlytics, Inc.
Delisting Announcement
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19